Start here if you're new
what it is
SolarMax sells and installs solar systems in the U.S. and lines up solar farm projects in China.
how it gets paid
Last year Solarmax Technology made $23M in revenue.
what just happened
Revenue reached $44M, but a 6.7% gross margin left almost no room for mistakes.
At a glance
n/a balance sheet
-$0.79 fy2024 eps est
$23M fy2024 rev est
n/a operating margin
~$38M market cap
What they do
SolarMax sells and installs solar systems in the U.S. and lines up solar farm projects in China.
This is not a classic moat story. SolarMax has 76 employees and a $38 million market cap, which is tiny next to the solar giants you already know. The real edge is reach across home installs, commercial work, and utility EPC work, but you should treat that as opportunity, not protection.
How they make money
$23M
annual revenue
total revenue
$23M
n/a
The products that matter
builds large solar and storage projects
Utility-scale EPC
$15M revenue · ~65% of total
it already contributes about $15M of the current revenue base, and management says it secured a $258M contract tied to a 600 MWh battery storage project in Texas.
the swing factor
designs and installs rooftop systems
Residential & Commercial Solar
$6M revenue · ~26% of total
this part of the business contributes about $6M. It keeps the company in front of homeowners and businesses, but it is not large enough to offset weak project economics elsewhere.
base business
manufactures and sells equipment
Solar Inverters & Panels
$2M revenue · ~9% of total
this is only about $2M of revenue. If you are looking for a manufacturing edge here, the numbers are too small to support that claim.
too small to matter yet
Key numbers
-144%
operating margin
Operating margin → profit after running the business → so what: SolarMax lost about $1.44 at the operating level for every $1 of revenue in 2024.
$10M
long-term debt
Long-term debt → money owed beyond one year → so what: $10 million is 21% of capital and about 43% of the company's $23 million annual revenue base.
-$0.79
2024 EPS est
EPS → profit per share → so what: the company is expected to lose $0.79 per share for 2024, so this is still a survival story, not a profit story.
5/100
price stability
Price stability → how steady the stock trades → so what: 5 out of 100 means you should expect wild swings, which is normal behavior for a $0.62 microcap.
Financial health
n/a
strength
- balance sheet grade n/a
- price stability 5 / 100
- long-term debt $10M (21% of capital)
n/a — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for SMXT right now.
source: institutional data · return history unavailable
What just happened
loss widened
Revenue reached $44M, but a 6.7% gross margin left almost no room for mistakes.
EDGAR shows latest-quarter revenue up 45% vs. prior year, while EPS fell to -$0.11. Yahoo lists last earnings at -$0.04, so there is a source mismatch; the SEC number carries more weight.
$44M
revenue
$0.11
eps
6.7%
gross margin
the number that mattered
Gross margin of 6.7% mattered most. Gross margin → money left after direct costs → growth helps less when only 6.7 cents of every dollar is left.
source: SEC filing, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is failing to fund and execute through a going-concern warning while under Nasdaq's $1 bid-price rule.
high
going-concern warning
The auditor said there is substantial doubt about the company's ability to continue operating for the next 12 months. That is not a footnote. It is the capital structure in one sentence.
If fresh financing does not arrive, equity holders are exposed to dilution, asset sales, or worse.
high
Nasdaq delisting risk
Nasdaq sent a notice on March 3, 2026 because the stock failed to maintain a $1.00 minimum bid price. The company has 180 days to regain compliance.
At a $0.62 share price, market access and investor interest can get worse before operations get better.
med
thin margins
Gross margin sits at 6.7–7.7%, and trailing profit margin is -18.4% on $50.85M in revenue. In human-speak: even when sales show up, not much sticks.
A single cost overrun can wipe out the economics of an entire project quarter.
med
project concentration and timing
A $258M contract sounds transformational because it is more than 11 times the current $23M annual revenue base. It also means one project can dominate the narrative.
Delay it, repricing it, or under-earning it would pressure both revenue confidence and financing options.
These risks expose a ~$38M equity value to funding pressure, listing pressure, and execution pressure all at once.
source: institutional data · regulatory filings · risk analysis
Pay attention to
listing risk
Nasdaq compliance clock
The company has 180 days from the March 3, 2026 notice to get back above $1.00 and stay there long enough to regain compliance.
calendar
Q4 2025 and full-year results
Watch whether the recent revenue jump holds into the next report. One good quarter is interesting. A second one starts to look like a business trend.
margin
gross margin above 6.7%
This is the kill criterion hiding in plain sight. If project volume rises and gross margin stays stuck near 6.7%, growth is not fixing the core problem.
execution
Texas battery project conversion
The question is not whether management can announce a $258M contract. The question is whether you see clean revenue conversion, margin, and cash collection behind it.
Analyst rankings
coverage
thin
Institutional ranking data is limited here. in human-speak: there is not enough broad analyst coverage to lean on consensus.
what that means
DIY
With little coverage, the stock can move on filings, financing, and listing headlines faster than on published targets.
read-through
high risk
Sparse coverage does not create hidden quality by itself. Sometimes it just means the company is too small, too early, or too messy for the Street.
source: institutional data
Institutional activity
institutional ownership data for SMXT is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$1
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive